글로벌 수의학 시장 – 2030년까지의 산업 동향 및 예측

수의학 시장 분석 및 규모

인간과 같은 동물은 박테리아, 기생충, 진균, 바이러스와 같은 많은 질병에 취약합니다. 수의학은 농업 동물과 애완동물이 더 오래 살고 더 건강하게 살 수 있도록 돕습니다. 애완동물의 기대 수명을 늘리려면 더 나은 식단과 의료 시설의 개발이 필요합니다. 애완동물의 수가 증가함에 따라 만성 질환이 증가합니다.

Data Bridge Market Research는 2023-2030년 예측 기간 동안 수의학 시장의 성장률을 분석합니다. 수의학 시장의 예상 CAGR은 언급된 예측 기간 동안 약 6.90%인 경향이 있습니다. 시장은 2022년에 249억 7천만 달러로 평가되었으며 2030년까지 425억 9천만 달러로 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

수의학 시장 범위 및 세분화

Market Definition

Veterinary medicine includes drugs such as anti-infectives and parasiticides that are provided to animals orally. Vaccines are also used in veterinary medicine to help immunity in animals against viral diseases such as equine influenza (EIV) and parainfluenza 3-respiratory syncytial virus. Medicated feed additives are mixed with animal feed to produce medicinal benefits in animals. Veterinary medicine is also used in a number of species, which includes companion animals such as dogs and cats along with livestock animals including cattle, pigs, and chickens

Veterinary Medicine Market Dynamics

Drivers

• Rising demand for pet insurance policies

The increasing use of pet health insurance to pay for veterinarian services in several industrialized countries is anticipated to boost the market growth. Canada, the U.K., and Sweden all have a flourishing pet health insurance sector. The wide use of pet health insurance has increased intensely in China. The increasing awareness and wide understanding of pet health and the increasing popularity of pets are two important parts that have aided in the adoption of pet healthcare insurance.

• Rising occurrences of zoonotic diseases among livestock animals

The rise in occurrences of zoonotic diseases among livestock animals will increase the numerous opportunities for the market's growth and influence market dynamics. The increased occurrence and financial burden of zoonotic illnesses among livestock animals boosted the livestock animals sector to occupy more than 63 % of the animal pharmaceuticals market share in the year 2020. Furthermore, bacterial parasites thrive by preying on farm animals, that causes huge sickness and financial hardship.

Opportunities

• Increasing Rate of Pet Owners

A major increase in the number of pet owners is boosting the need for better treatment options for companion animals, resulting in increased health expenditure on pets. As per the American Pet Products Association, the total spending in the U.S. pet industry rise to USD 103.6 billion in 2020 from USD 97.1 billion in 2019, and it is assessed to reach more than USD 109.6 billion in 2022.Furthermore, around 67% of households in the U.S. owned a pet, that is equal to approximately 84.9 million homes in 2020.

Restraints/Challenges

• High Cost of Treatment

The high cost of veterinary medicines are increasing with each passing day. The cost is quite high and thus it is limiting the market growth.

This veterinary medicine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the veterinary medicine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2020, Elanco acquired Bayer's Animal Health Business to expand its scale and capabilities, positioning it as a long-term leader in the lucrative and long-lasting animal health business

Global Veterinary Medicine Market Scope

The veterinary medicine market is segmented on the basis of product, animal type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Biologics
• Pharmaceuticals
• Medicated Feed Additives

Animal Type

• Production
• Companion

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Reference Laboratories
• Point-of-Care Testing/In-House Testing
• Veterinary Hospitals and Clinics
• Others

Veterinary Medicine Regional Analysis/Insights

The veterinary medicine market is analyzed and market size insights and trends are provided by product, animal type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the veterinary medicine market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market in the forecast period because of the wide presence of major market players and well-developed healthcare infrastructure in this region. In addition to this, the incidence of favourable government policies and growing initiatives to improve animal health will further propel the market's growth rate in this region.

Asia-Pacific is considered to grow over the coming years because of the wide expansion of manufacturing facilities and vaccination for livestock animals.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 또한 글로벌 브랜드의 존재와 가용성, 그리고 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다. 

경쟁 환경 및 글로벌 수의학 점유율 분석

수의학 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세입니다. 위에 제공된 데이터 포인트는 수의학 시장과 관련된 회사의 초점에만 관련이 있습니다.

수의학 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 머크앤코(미국)
• Bayer AG(독일)
• 베링거 인겔하임 인터내셔널 GmbH. (독일)
• 베토퀴놀(프랑스)
• 조에티스(미국)
• 세바(프랑스)
• 카길 주식회사(미국)
• Nutreco(네덜란드)
• 비르박(프랑스)
• Kindred Biosciences, Inc. (미국)
• 네오젠 코퍼레이션(미국)
• Hester Biosciences Limited. (인도)
• ADM(미국)
• 노브룩(영국)
• 데크라 파마슈티컬스 PLC(영국)
• Evonik Industries AG(독일)

SKU-53078